Vladimir Frecer

6PUBLICATIONS
10CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 28, 2026
In Silico Optimization of Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2.

Issouf Fofana, Brice Dali, Mawa Koné

|Apr 01, 2025
New potent N-hydroxycinnamamide-based histone deacetylase inhibitors suppress proliferation and trigger apoptosis in THP-1 leukaemia cells.

Magdalena Onuscakova, Tereza Kauerova, Eva Fialova

|Feb 26, 2025
Improved Inhibitors Targeting the Thymidylate Kinase of Multidrug-Resistant Mycobacterium tuberculosis with Favorable Pharmacokinetics.

Souleymane Konate, Koffi N'Guessan Placide Gabin Allangba, Issouf Fofana

|Apr 28, 2023
Structure-Based Design and Pharmacophore-Based Virtual Screening of Combinatorial Library of Triclosan Analogues Active against Enoyl-Acyl Carrier Protein Reductase of Plasmodium falciparum with Favourable ADME Profiles.

Cecile Bieri, Akori Esmel, Melalie Keita

|May 06, 2022
Antiviral agents against COVID-19: structure-based design of specific peptidomimetic inhibitors of SARS-CoV-2 main protease.

Vladimir Frecer, Stanislav Miertus

|Dec 14, 2017
How accurate is the description of ligand-protein interactions by a hybrid QM/MM approach?

Jakub Kollar, Vladimir Frecer

Pageof 1

Frequent Collaborators

3 joint publications

Eugene Megnassan

2 joint publications

Stanislav Miertus

1 joint publications

Tereza Kauerova

1 joint publications

Hana Pizova